Pharmaceuticals

GN Corporation and Edogawa Evolutionary Laboratory of Science Cosponsor International Academic Conference, NCRM NICHE 2019, on October 15, 2019

KOFU, Japan and TOKYO, Oct. 21, 2019 /PRNewswire/ -- GN Corporation Co., Ltd., a Japanese firm involved in research and development of technology in regenerative medicine, and Edogawa Evolutionary Laboratory of Science(EELS), a unit ofTokyo's Edogawa Hospital, cosponsored NCRM NICHE 2019 (www.ncr...

2019-10-21 14:00 172

Mundipharma Wins "Best Companies to Work for in Asia" Award in Singapore for Third Time Running

SINGAPORE, Oct. 21, 2019 /PRNewswire/ -- Healthcare industry leader Mundipharma has been awarded the title of "Best Companies to Work for inAsia" in Singapore by HR Asia for the third time running, in the pharmaceuticals category. Mundipharma...

2019-10-21 11:49 252

Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma

SUZHOU, China, Oct. 21, 2019 /PRNewswire/ --  Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today ...

2019-10-21 08:00 271

Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas

AUSTIN, Texas, Oct. 18, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that Dr. Heather Wilson-Robles DVM, DACVIM, Associate Professor and Dr. Fred and Vola N. Palmer Chair in Comparative Oncology, Texas A&M College of Veterinary Medicine & Biomedical S...

2019-10-18 20:30 2641

Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of Products

Concept Medical B.V. with its headquarters in Tampa, Florida has announced that on16th October 2019, they have received the CE certification for their MagicTouch group of products. HOEVELAKEN, Netherlands, Oct. 18, 2019 /PRNewswire/ -- The CE certified products/brands are as listed below: * M...

2019-10-18 10:07 405

China Biologic Special Committee Retains Financial Advisor and Legal Counsel

BEIJING, Oct. 17, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the special committee (the "Special Committee") of the Company's board o...

2019-10-17 20:00 3332

Envirotainer Opens RAP e2 Station in Liege (LGG)

UPPLANDS VASBY, Sweden, Oct. 17, 2019 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced that they are upgrading their network of stations supporting their state-of-the-art e-technology container, the RAP e2,...

2019-10-17 14:39 323

Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH

SHANGHAI, Oct. 16, 2019 /PRNewswire/ -- Hepagene Therapeutics, Inc, a clinical stage drug discovery and development company which devotes its efforts towards discovering, developing and delivering innovative medicines that help patients prevail over liver diseases, announced today that it has dos...

2019-10-16 18:00 179

Curiox Biosystems Achieves Commercialisation and Fund Raising Success in North Asia with the Support of Cornerstone Investor, ZIG Ventures

* CURIOX BIOSYSTEMS, is an A*STAR spinoff company, that develops bioinstrumentation solutions used in cell analysis and therapy for the pharmaceutical and biotech industries. The company has successfully penetrated theUSA, PRC, Korean and European markets and also secured a Series B funding of ...

2019-10-16 07:00 356

Movilitas Announces Featured Speakers for Track and Trace Conference in Kuala Lumpur

Conference's key themes include emerging regulations for serialization and traceability, challenges for different stakeholders of the life science industry, the role of GS1 standards and best-in-class practices COLUMBIA, Maryland, Oct. 16, 2019 /PRNewswire/ -- Movilitas, a technology leader deli...

2019-10-16 04:11 344

Systech Expands Market-Leading Brand Protection Solution for Improved Supply Chain Visibility

PRINCETON, New Jersey, Oct. 15, 2019 /PRNewswire/ -- Systech, a global technology leader in digital brand protection and product authentication, today announced a new release of theSystech Brand Protection Suite™—its fully integrated platform to combat counterfeiters, solve product diversion and ...

2019-10-15 21:00 307

Data Presented at 3rd Healthy Lung Summit 2019, Demonstrates Impact of AstraZeneca's Healthy Lung Partnership Programme in 9 Asian Countries

JAKARTA, Indonesia, Oct. 15, 2019 /PRNewswire/ -- Building on the continued success of the Healthy Lung Programme, today AstraZeneca and Business Sweden - The Swedish Trade & Invest Council host the 3rd Heathy Lung Summit, bringing together the Healthy Lung Taskforces from eight Asian countries a...

2019-10-15 16:17 5130

Collaborative Medicinal Development Enrolls First Patient In a Randomized, Placebo-Controlled Clinical Trial of CuATSM For The Treatment of Amyotrophic Lateral Sclerosis

MILL VALLEY, Calif. and MELBOURNE, Australia, Oct. 15, 2019 /PRNewswire/ -- Collaborative Medicinal Development, LLC) ("CMD"), a clinical stage biopharmaceutical company with a portfolio of candidates for treatment of neurological and neuropsychiatric diseases, announced today that it enrolled t...

2019-10-15 05:58 290

STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal

SINGAPORE and MELBOURNE, Australia, Oct. 14, 2019 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutics Asia (STA) has signed a new license deal, enabling it to provide a global advanced sarcoma therapy to patients inAustralia, New Zealand and throughout SE Asia. Under the ...

2019-10-14 14:00 249

Admedus Inks $A36.2M Deal for CardioCel And VascuCel Patch Business

Transaction Highlights: * Admedus has sold the distribution rights to its CardioCel® and VascuCel® product range for$A36.2 million (including all earnouts) to LeMaitre Vascular Inc. * $A22.8M upfront payment plus two instalments of $A1m each after 12 months and 36 months * Up to $A11.4M on...

2019-10-14 12:51 466

CMAB Biopharma and BJ Bioscience Establish an Exclusive Strategic Partnership

* The new partnership will combine the research and development ingenuity of BJ Bioscience with the state-of-art biologics manufacturing set up of CMAB * CMAB will provide full development and manufacturing services for BJ Bioscience's BJ-005 bi-functional antibody * BJ-005 is planned to ent...

2019-10-11 18:00 1391

Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S.

SHANGHAI, Oct. 11, 2019 /PRNewswire/ -- Kangpu Biopharmaceuticals announced today that it has successfully completed a first-in-human phase I single ascending dose (SAD) clinical study of KPG-818 conducted inthe United States. This randomized, double-blind, placebo-controlled study evaluated the...

2019-10-11 13:00 330

Bayer G4A Partners With Wellthy Therapeutics

MUMBAI, India, Oct. 11, 2019 /PRNewswire/ -- Wellthy Therapeutics, South Asia's leading digital therapeutics (DTx) company today announced its partnership with Bayer (BAYN: DE) through its G4A partnership initiative. Wellthy Therapeutics stands out as onefrom over 750 digital health companies spr...

2019-10-11 09:00 708

MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services

YANTAI, China, Oct. 10, 2019 /PRNewswire/ -- Based on its recent analysis of the global antibody drug conjugate (ADC) contract manufacturing services market, Frost & Sullivan recognizesChina-based MabPlex International, Ltd (MabPlex) with the 2019 Global Growth Excellence Leadership Award. MabPle...

2019-10-10 21:00 432

Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors

SUZHOU, China and LONDON, Oct. 10, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801) and Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announced the expansion of their global collaboration agreement to evaluate the safety and efficacy of Innovent's Ty...

2019-10-10 15:55 3264
12345 ... 97